CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 63 filers reported holding CABALETTA BIO INC in Q2 2021. The put-call ratio across all filers is 4.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,562,485 | +64.8% | 299,769 | +39.8% | 0.00% | 0.0% |
| Q2 2023 | $2,768,962 | +734.0% | 214,482 | +434.2% | 0.00% | – |
| Q1 2023 | $332,016 | +5.0% | 40,147 | +17.4% | 0.00% | – |
| Q4 2022 | $316,313 | +1564.8% | 34,196 | +16.7% | 0.00% | – |
| Q3 2022 | $19,000 | -38.7% | 29,307 | 0.0% | 0.00% | – |
| Q2 2022 | $31,000 | -47.5% | 29,307 | 0.0% | 0.00% | – |
| Q1 2022 | $59,000 | -46.8% | 29,307 | 0.0% | 0.00% | – |
| Q4 2021 | $111,000 | -63.5% | 29,307 | +17.4% | 0.00% | – |
| Q3 2021 | $304,000 | +38.8% | 24,970 | -2.2% | 0.00% | – |
| Q2 2021 | $219,000 | -84.8% | 25,521 | -80.4% | 0.00% | – |
| Q1 2021 | $1,445,000 | -17.0% | 130,168 | -6.8% | 0.00% | – |
| Q4 2020 | $1,742,000 | +11.0% | 139,625 | -3.5% | 0.00% | – |
| Q3 2020 | $1,569,000 | +7.8% | 144,699 | +10.8% | 0.00% | – |
| Q2 2020 | $1,455,000 | +104.4% | 130,626 | +34.1% | 0.00% | – |
| Q1 2020 | $712,000 | -24.2% | 97,435 | +44.9% | 0.00% | – |
| Q4 2019 | $939,000 | – | 67,231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,454,627 | $20,299,765 | 16.92% |
| VR Adviser, LLC | 1,973,251 | $16,318,786 | 3.19% |
| COMMODORE CAPITAL LP | 1,835,000 | $15,175,450 | 2.31% |
| Velan Capital Investment Management LP | 250,000 | $2,067,500 | 1.76% |
| Cormorant Asset Management, LP | 1,821,739 | $15,066 | 0.99% |
| CAXTON CORP | 40,581 | $335,602 | 0.85% |
| TCG Crossover Management, LLC | 486,795 | $4,025,795 | 0.78% |
| Boxer Capital, LLC | 540,000 | $4,466 | 0.22% |
| FRED ALGER MANAGEMENT, LLC | 4,015,310 | $33,206,614 | 0.18% |
| Perceptive Advisors | 724,777 | $5,993,906 | 0.18% |